PROVIDE SUPERIOR CLINICAL SERVICE
Zio XT’s proven higher diagnostic yield over Holter allows you to provide the best clinical service for your arrhythmia patient. In fact, in a head-to-head comparison with Holter, Zio XT enabled doctors to make a meaningful change in clinical management for 28.4% of patients with atrial fibrillation.
Rosenberg, M., et al. Use of a Noninvasive Continuous Monitoring Device in the Management of Atrial Fibrillation: A Pilot Study. Pacing and Clinical Electrophysiology, 2013.
DOWNLOAD MORE INFORMATION